PROGENTEC DIAGNOSTICS
Progentec Diagnostics was set up to explore and commercialize state of the art diagnostic interventions in therapeutic areas with a high level of unmet need. The company is collaborating with a number of research institutions and individuals around the world engaged in bringing the latest technological innovations to the field of diagnostics. The commitment to this cause is firmly rooted in our belief that better diagnostics would not only help in better and less costly management of diseases, but also help tremendously in reducing the incidence of diseases through early screening and detection.
PROGENTEC DIAGNOSTICS
Industry:
Biotechnology Health Care Health Diagnostics Medical Therapeutics
Founded:
2015-07-21
Address:
Oklahoma City, Oklahoma, United States
Country:
United States
Website Url:
http://www.progentec.com
Total Employee:
1+
Status:
Active
Contact:
405.216.4818
Email Addresses:
[email protected]
Total Funding:
6.25 M USD
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-07-30 | Karate Health | Karate Health acquired by Progentec Diagnostics | N/A |
2018-11-02 | LupusCorner | LupusCorner acquired by Progentec Diagnostics | N/A |
Investors List
Oklahoma Seed Capital Fund
Oklahoma Seed Capital Fund investment in Series A - Progentec Diagnostics
Mayo Clinic Ventures
Mayo Clinic Ventures investment in Series A - Progentec Diagnostics
Plains Venture Partners
Plains Venture Partners investment in Series A - Progentec Diagnostics
Stanford University
Stanford University investment in Series A - Progentec Diagnostics
OCA Ventures
OCA Ventures investment in Series A - Progentec Diagnostics
NMC Health
NMC Health investment in Series A - Progentec Diagnostics
NMC Lifesciences
NMC Lifesciences investment in Venture Round - Progentec Diagnostics
i2E
i2E investment in Venture Round - Progentec Diagnostics
OCA Ventures
OCA Ventures investment in Venture Round - Progentec Diagnostics
i2E
i2E investment in Venture Round - Progentec Diagnostics
Official Site Inspections
http://www.progentec.com Semrush global rank: 5.84 M Semrush visits lastest month: 1.42 K
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013